Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
66,775,280
-
Number of holders
-
208
-
Total 13F shares, excl. options
-
71,891,483
-
Shares change
-
-65,443
-
Total reported value, excl. options
-
$5,485,539,377
-
Value change
-
+$5,743,600
-
Put/Call ratio
-
160%
-
Number of buys
-
123
-
Number of sells
-
-79
-
Price
-
$76.30
Significant Holders of Nuvalent, Inc. - Class A Stock (NUVL) as of Q2 2025
248 filings reported holding NUVL - Nuvalent, Inc. - Class A Stock as of Q2 2025.
Nuvalent, Inc. - Class A Stock (NUVL) has 208 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 71,891,483 shares
.
Largest 10 shareholders include DEERFIELD MANAGEMENT COMPANY, L.P. (17,991,024 shares), FMR LLC (9,968,846 shares), Paradigm Biocapital Advisors LP (5,269,433 shares), VANGUARD GROUP INC (4,524,124 shares), BlackRock, Inc. (4,046,256 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,795,373 shares), JANUS HENDERSON GROUP PLC (1,782,581 shares), WELLINGTON MANAGEMENT GROUP LLP (1,576,374 shares), STATE STREET CORP (1,490,279 shares), and Bain Capital Life Sciences Investors, LLC (1,447,267 shares).
This table shows the top 208 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.